Eli Lilly To Buy German Animal Health Business Lohmann
U.S. pharmaceutical giant Eli Lilly & Co. will acquire German animal vaccine maker Lohmann SE for an undisclosed price in a deal that allows Eli Lilly to further expand its animal...To view the full article, register now.
Already a subscriber? Click here to view full article